A WS12-releasing contact lens is described as well as method of manufacturing the same. The WS12-releasing contact lens comprises a polymeric lens body and WS12 releasably adhered to the polymeric lens body, and releases from 0.05 g to 0.5 g WS12 after 1 hour in a release media or when worn by a human subject. The WS12-releasing contact lens can be comfortably worn by a symptomatic contact lens wearer and can increase the duration of comfortable lens wearing time and/or reduce lens awareness events and/or reduce contact lens dryness in a symptomatic contact lens wearer.

A WS12-releasing contact lens is described as well as method of manufacturing the same. The WS12-releasing contact lens comprises a polymeric lens body and WS12 releasably adhered to the polymeric lens body, and releases from 0.05 ?g to 0.5 ?g WS12 after 1 hour in a release media or when worn by a human subject. The WS12-releasing contact lens can be comfortably worn by a symptomatic contact lens wearer and can increase the duration of comfortable lens wearing time and/or reduce lens awareness events and/or reduce contact lens dryness in a symptomatic contact lens wearer.

An eye treatment apparatus is described. The apparatus includes an annular body that has a hollow optical zone in its center. An inner perimeter of the annular body surrounds the optical zone. The inner perimeter has a diameter that corresponds to a diameter of the eye's cornea. An outer perimeter of the annular body has a diameter such that the annular body can extend to underneath the eye lid in an open eye position when the eye treatment apparatus is in operation. In this way, the apparatus can be worn on the eye, where the hollow optical zone substantially corresponds to the cornea and does not interfere with the field of vision. The annular body also includes a storage chamber that stores therapeutic liquid for an eye. An outlet is coupled with the storage chamber such that, in operation, the therapeutic liquid can be dispensed to the eye.

The present invention provides a smart contact lens including a sensor capable of non-invasively sensing an eye disease in real time and a drug reservoir, and smart glasses for controlling the smart contact lens.

A contact lens may include a lens comprising a hydrogel configured to be worn on an eyeball. A contact lens may include an electronic component fully encapsuled within the lens, wherein the electronic component may include a sensor, a battery, a supercapacitor, an electronically controlled microfluidic channel, or combinations thereof. Methods for producing such a contact lens are also disclosed.

One embodiment of a contact lens includes a lens body configured to fit directly on the surface of the eye and legible characters positioned on the lens body. Another embodiment of a contact lens comprises a lens body including polymeric material and a lens enhancing material (e.g., ink, silicone material, medicament material, and the like) encapsulated in the polymeric material. The lens enhancing material can be in the form of isolated sections distributed in the surrounding polymeric material. Methods of making contact lenses include forming a first lens layer including a first surface, forming a pattern on the first surface, and forming a second lens layer over the pattern.

The present invention relates to a method of manufacturing a sustained drug-release contact lens. More specifically, the present invention relates to a method of manufacturing a sustained drug-release contact lens, the method including: forming a body in which the body provides an outer shape of the lens and has a plurality of cavities configured to be recessed and spaced apart from each other by a predetermined distance along a side surface of the contact lens; and filling a drug and forming a closing part in which the cavities of the body formed at the forming the body are filled with the drug and respective closing parts closing the cavities are formed, wherein the closing part is made of a biodegradable material and each closing part is configured to open at a different time during wearing of the contact lens at the forming the body.

A contact lens is disclosed. The contact lens includes a gel substrate. The gel substrate includes astaxanthin having a mass percentage of 0.004% to 5%. The hydrogel composition and a method for manufacturing the contact lens are also disclosed.

A method for introducing an active compound into a soft hydrated contact lens comprising the steps of: providing a hypotonic aqueous solution having an osmolarity value less than 150 mOsm and an effective quantity of that active compound, immersing the soft contact lens in the aqueous hypotonic solution, subjecting the contact lens immersed in the aqueous hypotonic solution to mechanical vibrations having a power greater than 100 mW for a predetermined time.

A contact lens for collecting tear or delivering a drug includes an inner lens placed on an eyeball, an outer lens provided at an outer side of the inner lens to overlap the inner lens, and a plurality of pillars disposed between the inner lens and the outer lens to form a space between the inner lens and the outer lens, wherein the contact lens has a plurality of interfacing ports for connecting a chamber with an outside of the contact lens.